- Home
- BMRN vs LEVI Comparison
BMRN vs LEVI Comparison
Compare BMRN & LEVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- LEVI
- Stock Information
- Founded
- BMRN 1996
- LEVI 1853
- Country
- BMRN United States
- LEVI United States
- Employees
- BMRN N/A
- LEVI N/A
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- LEVI Apparel
- Sector
- BMRN Health Care
- LEVI Consumer Discretionary
- Exchange
- BMRN Nasdaq
- LEVI Nasdaq
- Market Cap
- BMRN 10.0B
- LEVI 9.1B
- IPO Year
- BMRN 1999
- LEVI 2019
- Fundamental
- Price
- BMRN $52.08
- LEVI $19.46
- Analyst Decision
- BMRN Buy
- LEVI Strong Buy
- Analyst Count
- BMRN 19
- LEVI 12
- Target Price
- BMRN $90.89
- LEVI $26.25
- AVG Volume (30 Days)
- BMRN 2.8M
- LEVI 3.9M
- Earning Date
- BMRN 10-27-2025
- LEVI 10-09-2025
- Dividend Yield
- BMRN N/A
- LEVI 2.88%
- EPS Growth
- BMRN 59.53
- LEVI 303.84
- EPS
- BMRN 2.68
- LEVI 1.51
- Revenue
- BMRN $3,094,001,000.00
- LEVI $6,589,400,000.00
- Revenue This Year
- BMRN $13.32
- LEVI N/A
- Revenue Next Year
- BMRN $7.51
- LEVI $5.28
- P/E Ratio
- BMRN $19.59
- LEVI $12.88
- Revenue Growth
- BMRN 12.39
- LEVI 11.22
- 52 Week Low
- BMRN $51.00
- LEVI $12.17
- 52 Week High
- BMRN $73.51
- LEVI $24.82
- Technical
- Relative Strength Index (RSI)
- BMRN 42.64
- LEVI 30.03
- Support Level
- BMRN $51.80
- LEVI $20.72
- Resistance Level
- BMRN $54.25
- LEVI $21.49
- Average True Range (ATR)
- BMRN 1.73
- LEVI 0.58
- MACD
- BMRN -0.03
- LEVI -0.17
- Stochastic Oscillator
- BMRN 18.34
- LEVI 6.10
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
About LEVI Levi Strauss & Co
Levi Strauss & Co is involved in designing, marketing, and selling products that include jeans, casual and dresses pants, tops, shorts, skirts, jackets, footwear, and related accessories directly or through third parties and licensees for men, women, and children under Levi's, Dockers, Signature by Levi Strauss & Co. and Denizen brands. The company manages its business according to three regional segments: the Americas, which is the key revenue driver; Europe; and Asia.